Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients.

Thrombosis and haemostasis - 1 Jan 2016

Ferroni Patrizia, Palmirotta Raffaele, Riondino Silvia, De Marchis Maria Laura, Nardecchia Antonella, Formica Vincenzo, Guadagni Fiorella, Roselli Mario

Abstract excerpt

Among the possible genetic contributors to cancer-related venous thromboembolism (VTE), vascular endothelial growth factor (VEGFA) could play an important role, as an imbalance of the VEGFA system (either disease-related or drug-induced) may result in a disturbance of vascular homeostasis. Thus, this study was designed to investigate the predictive role of eight different VEGFA gene promoter single nucleotide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Promoter Regions, Genetic
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Gene Frequency

Share to Genetic Predisposition to Disease

Share to Haplotypes

Share to Phenotype

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 26336029
DOI: 10.1160/TH15-03-0259

Genes

VEGFA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients.PMID 26336029Read ↗

TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy.Semantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.Semantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocolSemantic proximity Read ↗

The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.Semantic proximity Read ↗

Associations of tumor somatic mutations with cancer-associated venous thromboembolism.Semantic proximity Read ↗

Potential utility of comprehensive genomic profiling to predict venous thromboembolism in patients with solid cancer.Semantic proximity Read ↗

Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event.Semantic proximity Read ↗

Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control StudySemantic proximity Read ↗

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.